# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-22-016231
Filing Date
2022-04-27
Accepted
2022-04-27 16:14:32
Documents
4
Period of Report
2022-06-09

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | edge20003421x1_def14a.htm | DEF 14A | 637296
2 |  | edge20003421x1_pc01.jpg | GRAPHIC | 596838
3 |  | edge20003421x1_pc02.jpg | GRAPHIC | 432358
4 |  | sig_douglaslove.jpg | GRAPHIC | 12364
| Complete submission text file | 0001140361-22-016231.txt |  | 2072040

Mailing Address 1400 SIERRA POINT PARKWAY BLDG C SUITE 200 BRISBANE CA 94005
Business Address 1400 SIERRA POINT PARKWAY BLDG C SUITE 200 BRISBANE CA 94005 (650)-822-5500
Annexon, Inc. (Filer) CIK: 0001528115 (see all company filings)

EIN.: 275414423 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39402 | Film No.: 22859721
SIC: 2834 Pharmaceutical Preparations